These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20375599)

  • 1. Defensins in viral infections.
    Ding J; Chou YY; Chang TL
    J Innate Immun; 2009; 1(5):413-20. PubMed ID: 20375599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives for clinical use of engineered human host defense antimicrobial peptides.
    Pachón-Ibáñez ME; Smani Y; Pachón J; Sánchez-Céspedes J
    FEMS Microbiol Rev; 2017 May; 41(3):323-342. PubMed ID: 28521337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defensins: A Double-Edged Sword in Host Immunity.
    Xu D; Lu W
    Front Immunol; 2020; 11():764. PubMed ID: 32457744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.
    LeMessurier KS; Lin Y; McCullers JA; Samarasinghe AE
    Antiviral Res; 2016 Sep; 133():208-17. PubMed ID: 27531368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defensins in innate antiviral immunity.
    Klotman ME; Chang TL
    Nat Rev Immunol; 2006 Jun; 6(6):447-56. PubMed ID: 16724099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Oral Defensins Antimicrobial Peptides: A Future Promising Antimicrobial Drug.
    Khurshid Z; Zafar MS; Naseem M; Khan RS; Najeeb S
    Curr Pharm Des; 2018; 24(10):1130-1137. PubMed ID: 29611481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defensins in Viral Infection and Pathogenesis.
    Holly MK; Diaz K; Smith JG
    Annu Rev Virol; 2017 Sep; 4(1):369-391. PubMed ID: 28715972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Activities of Human Host Defense Peptides.
    Brice DC; Diamond G
    Curr Med Chem; 2020; 27(9):1420-1443. PubMed ID: 31385762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defensin participation in innate and adaptive immunity.
    Yang D; Liu ZH; Tewary P; Chen Q; de la Rosa G; Oppenheim JJ
    Curr Pharm Des; 2007; 13(30):3131-9. PubMed ID: 17979754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defensins and other antimicrobial peptides: a historical perspective and an update.
    Ganz T
    Comb Chem High Throughput Screen; 2005 May; 8(3):209-17. PubMed ID: 15892623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defensins at the Mucosal Surface: Latest Insights into Defensin-Virus Interactions.
    Wilson SS; Wiens ME; Holly MK; Smith JG
    J Virol; 2016 Jun; 90(11):5216-5218. PubMed ID: 27009960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of defensins in virus-induced asthma.
    Proud D
    Curr Allergy Asthma Rep; 2006 Feb; 6(1):81-5. PubMed ID: 16476200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial peptides: general overview and clinical implications in human health and disease.
    Guaní-Guerra E; Santos-Mendoza T; Lugo-Reyes SO; Terán LM
    Clin Immunol; 2010 Apr; 135(1):1-11. PubMed ID: 20116332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising role of defensins peptides as therapeutics to combat against viral infection.
    Solanki SS; Singh P; Kashyap P; Sansi MS; Ali SA
    Microb Pathog; 2021 Jun; 155():104930. PubMed ID: 33933603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Human β-Defensin-1 Production by Viruses.
    Ryan LK; Diamond G
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28635669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Antimicrobial Peptides as Therapeutics for Viral Infections.
    Ahmed A; Siman-Tov G; Hall G; Bhalla N; Narayanan A
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31374901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial peptides as effector molecules of mammalian host defense.
    Bevins CL
    Contrib Microbiol; 2003; 10():106-48. PubMed ID: 12530324
    [No Abstract]   [Full Text] [Related]  

  • 18. Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering.
    Skeate JG; Segerink WH; Garcia MD; Fernandez DJ; Prins R; Lühen KP; Voss FO; Da Silva DM; Kast WM
    Front Immunol; 2020; 11():561843. PubMed ID: 33154746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic Peptides as Novel Therapeutic Microbicides: Engineering of Human Defensin Mimetics.
    Falanga A; Nigro E; De Biasi MG; Daniele A; Morelli G; Galdiero S; Scudiero O
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28726740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Defensins from Antivirals to Vaccine Adjuvants: Rediscovery of the Innate Immunity Arsenal.
    Zupin L; Crovella S
    Protein Pept Lett; 2022; 29(2):121-124. PubMed ID: 34823454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.